|Articles|December 1, 2004

Novel filler found safe, durable

San Diego - Results from a U.S. Food and Drug Administration pivotal trial demonstrate that the injectable wrinkle filler Artecoll, composed of polymethylmethacralate (PMMA) microspheres (20 percent) suspended in an ultra-purified collagen carrier (80 percent) is an equally safe, but longer-lasting, alternative to bovine collagen for the cosmetic correction of a variety of facial contour defects, Steven R. Cohen, M.D., tells Dermatology Times.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.


Latest CME